1. Home
  2. TLRY

as 10-29-2025 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Stocks

Health Care

Medicinal Chemicals and Botanical Products

Nasdaq

Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure comes mostly from alcohol.

Founded: N/A Country:
Canada
Canada
Employees: N/A City: NEW YORK
Market Cap: 1.7B IPO Year: 2018
Target Price: $1.50 AVG Volume (30 days): 96.0M
Analyst Decision: Buy Number of Analysts: 3
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -2.30 EPS Growth: N/A
52 Week Low/High: $0.35 - $2.32 Next Earning Date: 10-09-2025
Revenue: $830,766,000 Revenue Growth: 2.31%
Revenue Growth (this year): 7.28% Revenue Growth (next year): 4.56%

Share on Social Networks: